Patent Assignment
Reel/Frame 054835/0297
Assignment of Assignor's Interest
Recorded: 2021-01-06
Pages: 12
Assignors
POWLESLAND, ALEX
Executed: 2018-12-20
CHESTER, FIONA
Executed: 2019-01-09
POPA, ALINA
Executed: 2019-02-28
Assignee
IMMUNOCORE LIMITED
92 PARK DRIVE, MILTON PARK, ABINGDON, OXFORDSHIRE, OX14 4RY, UNITED KINGDOM
Covered Property
(1)
Peptides Derived from Kallikrein 4
Application:
16/998,945 →
Publication:
US 2021/0047629
Related Assignments
(3)
Other recorded transfers of the patent in this record — the chain of ownership.
Security Interest
Nov 6, 2020
From: IMMUNOCORE LIMITED; IMMUNOCORE LLC; IMMUNOCORE COMMERCIAL LLC
To: OXFORD FINANCE LUXEMBOURG S.À R.L., REGISTERED WITH THE LUXEMBOURG COMMERCIAL REGISTER UNDER NUMBER B243395, ACTING IN RESPECT OF ITS COMPARTMENT 1
Reel/Frame 054344/0218 →
Assignment of Assignor's Interest
Feb 2, 2021
From: IMMUNOCORE LTD.
To: IMMUNOCORE LIMITED; ADAPTIMMUNE LIMITED
Reel/Frame 055113/0241 →
Release of Security Interest
Nov 10, 2022
From: OXFORD FINANCE LUXEMBOURG S.À R.L
To: IMMUNOCORE LIMITED; IMMUNOCORE LLC; IMMUNOCORE COMMERCIAL LLC
Reel/Frame 061916/0493 →